Proteome patterns in uremic plasma

Blood Purification

Volumn 26, Issue 6, 2008, Pages 561-568

  Naseeb, Uzma ^a,b   Shafqat, Jawed ^a   Jägerbrink, Theres ^a   Zarina, Shamshad ^b   Alvestrand, Anders ^a   Jörnvall, Hans ^a   Axelsson, Jonas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Chronic kidney disease; End stage renal disease; HPLC separation; Mass spectrometry; Plasma; Protein

Indexed keywords

PEPTIDE; PLASMA PROTEIN; PROTEOME;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROL GROUP; CONTROLLED STUDY; DIALYSIS; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FINGER DERMATOGLYPHICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NORMAL HUMAN; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; UREMIA;

ADULT; AGED; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROTEOMICS; TANDEM MASS SPECTROMETRY; UREMIA;

EID: 57049132096     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000178773     Document Type: Article

References (34)

1. Renkin EM, Gilmore JP: Glomerular Filtration. Section 8: Renal Physiology in Handbook of Physiology. Washington, American Physiologic Society, 1973.
2. Martin KJ, Hruska KA, Lewis J, Anderson C, Slatopolsky E: The renal handling of parathyroid hormone. Role of peritubular uptake and glomerular filtration. J Clin Invest 1977;60:808-814.
3. Waldmann TA, Strober W, Mogielnicki RP: The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. J Clin Invest 1972;51:2162-2174.
4. Lin F-K, Suggs S, Lin C-H, et al: Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985;82:7580-7584.
5. Persson PB: Renin: origin, secretion and synthesis. J Physiol 2003;552:667-671.
6. Xu J, Li G, Wang P, et al: Renalase is a novel soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 2005;115:1275-1280.
7. Vanholder R, Meert N, Schepers E, Glorieux G: Uremic toxins: do we know enough to explain uremia? Blood Purif 2008;26:77-81.
8. Weissinger EM, Nguyen-Khoa T, Fumeron C, et al: Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics 2006;6:993-1000.
9. Weissinger EM, Wittke S, Kaiser T, et al: Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int 2004;65:2426-2434.
10. Nguyen MT, Ross GF, Dent CL, Devarajan P: Early prediction of acute renal injury using urinary proteomics. Am J Nephrol 2005;25:318-326.
11. Park MR, Wang EH, Jin DC, et al: Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Proteomics 2006;6:1066-1076.
12. Rossing K, Mischak H, Parving HH, et al: Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney Int 2005;68:193-205.
13. Mischak H, Kaiser T, Walden M, et al: Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond) 2004;107:485-495.
14. Haubitz M, Wittke S, Weissinger EM, et al: Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int 2005;67:2313-2320.
15. Molina H, Bunkenborg J, Reddy GH, et al: A proteomic analysis of human hemodialysis fluid. Mol Cell Proteomics 2005;4:637-650.
16. Kaiser T, Hermann A, Kielstein JT, et al: Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluid. J Chromatogr A 2003;1013:157-171.
17. Zolotarjova N, Mrozinski P, Chen H, Martosella J: Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum. J Chromatogr A 2007;1189:332-338.
18. Lexander H, Palmberg C, Auer G, et al: Proteomic analysis of protein expression in prostate cancer. Anal Quant Cytol Histol 2005;27:263-272.
19. Tollin M, Jägerbrink T, Haraldsson A, Agerberth B, Jörnvall H: Proteome analysis of vernix caseosa. Pediatr Res 2006;60:430-434.
20. Martosella J, Zolotarjova N, Liu H, et al: Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. J Proteome Res 2005;4:1522-1537.
21. Axelsson J, O'Byrne S, Qureshi AR, et al: Serum retinol-binding protein concentration and its association with uremic dysmetabolism in non-diabetic end-stage renal disease patients. Am J Nephrol 2008 (in press).
22. Bergström J, Heimbürger O, Lindholm B, Qureshi AR: Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis patients. J Am Soc Nephrol 1995;6:573.
23. Okubo K, Ikewaki K, Sakai S, et al: Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study. J Am Soc Nephrol 2004;15:1008-1015.
24. Hadders MA, Beringer DX, Gros P: Structure of C8 α -MACPF reveals mechanism of membrane attack in complement immune defense. Science 2007;317:1552-1554.
25. Foley RN, Guo H, Snyder JJ, et al: Septicemia in the United States dialysis population, 1991-1999. J Am Soc Nephrol 2004;15:1038-1045.
26. Deppisch RM, Beck W, Goehl H, Ritz E: Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int Suppl 2001;78:S271-S277.
27. Cohen G, Haag-Weber M, Horl WH: Immune dysfunction in uremia. Kidney Int 1997;62:S79-S82.
28. Horl WH, Wanner C, Schollmeyer P, Ogawa M: Plasma levels of pancreatic secretory trypsin inhibitor in relation to amylase and lipase in patients with acute and chronic renal failure. Nephron 1988;49:33-38.
29. Thomas GJ, Yung S, Davies M: Bikunin present in human peritoneal fluid is in part derived from the interaction of serum with peritoneal mesothelial cells. Am J Pathol 1998;153:1267-1276.
30. Yang Q, Graham TE, Mody N, et al: Serum retinol binding protein-4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362.
31. Graham TE, Yang Q, Blüher M, et al: Retinol-binding protein-4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;355:2552-2563.
32. Promintzer M, Krebs M, Todoric J, et al: Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab 2007;92:4306-4312.
33. Liz MA, Faro CJ, Saraiva MJ, Sousa MM: Transthyretin, a new cryptic protease. J Biol Chem 2004;279:21431-21438.
34. Schiffer E, Mischak H, Vanholder RC: Exploring the uremic toxins using proteomic technologies. Contrib Nephrol. Basel, Karger, 2008, vol 160, pp 159-171.